📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

In vivo relevant mixed urolithins and ellagic acid inhibit phenotypic and molecular colon cancer stem cell features: A new potentiality for ellagitannin metabolites against cancer. (2016)

First Author: Núñez-Sánchez MÁ

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.fct.2016.03.011

PubMed Identifier: 26995228

Publication URI: http://europepmc.org/abstract/MED/26995228

Type: Journal Article/Review

Volume: 92

Parent Publication: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association

ISSN: 0278-6915